More investors in the pharmaceutical industry are coming out to support the access to medicine index, which ranks pharmaceutical companies’ efforts to improve global access to medicines…In a statement soon after signing the index, the investors said how the pharmaceutical industry “…responds to the access to medicine issue could impact materially on long-term shareholder value.” They affirmed that access to healthcare should be viewed as a basic human right…The investors who signed up to the access to medicine index include AMP Capital [part of AMP Group], Sarasian, Ethos, F&C, Henderson, Aviva, Schroders, Natixis and SMPS…[also refers to GlaxoSmithKline]